SOPHiA GENETICS
Buying intent
32 tracked signals | Top 15 topics are below | Marketing and Sales are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere SOPHiA GENETICS's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
12d ago
13d ago
17d ago
13d ago
31d ago
29d ago
29d ago
12d ago
10d ago
18d ago
10d ago
13d ago
25d ago
13d ago
23d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at SOPHiA GENETICS
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileSOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer an
Top accounts researching SOPHiA GENETICS
names withheld on the public pageThese are companies whose own people brought up SOPHiA GENETICS unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
SOPHiA GENETICS's own team shows 5 signals on this topic. No one outside SOPHiA GENETICS has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Hiring75,708 cos · 411,263 people
- Leadership Development24,131 cos · 93,859 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 4 people; Marketing — 1 person; Leadership — 1 person
What's been said
public posts mentioning SOPHiA GENETICSUp to 9 public excerpts naming SOPHiA GENETICS from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
Blood-based comprehensive genomic profiling tests using circulating tumor DNA have been approved in Japan , but that’s just the starting line. Timing of use, reimbursement pathways, and clinical integration remain genuinely complex questions. The real strategic imperative is building testing capacity within Japan itself — moving away from overseas laboratory dependency. Getting turnaround times competitive, reimbursement aligned, and clinical workflows embedded locally is what actually matters for patients. Join our talk with Philippe Menu , SOPHiA GENETICS , and Michel Mommejat , A.D.A.M. Innovations (formerly Genesis Healthcare – GeneLife) as we explore how to translate the global vision of liquid biopsy into the local realities that matter in Japan. If you’re attending, let’s connect. Always better to share insights over coffee than slides.
May 2026